China Develops Research Sector (China)
This article was originally published in PharmAsia News
Executive Summary
An increasing number of international corporations are investing in the Chinese research and development sector. A recent survey by the Organization for Economic Co-Operation and Development (OECD) shows pharmaceutical discovery is just one of the many R&D fields expanding in China. Patent applications have doubled every two years. The R&D-to-gross domestic product ratio has doubled in the last ten, from .6 percent to 1.34 percent. Major international pharmaceutical companies, including Novartis, are further fueling this trend by announcing expanded research facilities in China. According to the OECD survey, much of this expansion is leaning toward the discovery and development of new products. In the past, most China-based R&D was limited to altering already established products to suit the Chinese market. (Click here for more - May Require Paid Subscription